Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5VBV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,143
Award facts
- Contract value 100% obligated
- $30,142.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $30,142.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens on December 11, 2025, with completion scheduled for December 12, 2025. This non-set-aside contract represents a pediatric or adult pharmaceutical supply for treating eczema, asthma, or chronic rhinosinusitis, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, holds extensive contract relationships with the Defense Logistics Agency and supports multiple federal healthcare systems including the Defense Health Agency and U.S. Coast Guard. The company's contract portfolio demonstrates consistent capability in meeting federal procurement requirements through competitive awards across diverse pharmaceutical therapeutic domains, from specialty medications to vaccines and medical supplies. This delivery order exemplifies the company's role as a key supplier within the military healthcare supply chain under DLA's pharmaceutical prime vendor framework.
Quick answers
Who was awarded contract SPE2DR26F5VBV?
SPE2DR26F5VBV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26F5VBV worth?
The government has obligated $30,143 on SPE2DR26F5VBV.
Is contract SPE2DR26F5VBV an order under another contract?
Yes. SPE2DR26F5VBV is a delivery order under SPE2DR25D2105, an indefinite delivery contract.
Was contract SPE2DR26F5VBV competed?
The extent of competition for SPE2DR26F5VBV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award